An engineered live biotherapeutic protects the intestinal microbiome against unwanted consequences of antibiotic therapies and could be developed as a simple and effective co-therapy.
Researchers engineered a method that allows bacteria to use light for external energy to accelerate biomanufacturing of target compounds without disrupting the host microorganism's natural metabolism.
